Skip to main content
. Author manuscript; available in PMC: 2018 Apr 27.
Published in final edited form as: Clin Cancer Res. 2011 Oct 12;17(24):7723–7731. doi: 10.1158/1078-0432.CCR-11-0990

Figure 2.

Figure 2

A, Kaplan–Meier curve for the KRAS-LCS6 variant, KRAS mutations and cause-specific survival in early-stage (stage I and II) CRC, P = 0.875. B, Kaplan–Meier curve for the KRAS-LCS6 variant, KRAS mutations and cause-specific survival in stage III CRC. C, Kaplan–Meier curve for the KRAS-LCS6 variant, KRAS mutations and cause-specific survival in stage IV CRC.